Keywords: پس از پیوند سیکلوفسفامید; Post-transplantation cyclophosphamide; Haploidentical; Graft-versus-host disease; Transplantation; BMT;
مقالات ISI پس از پیوند سیکلوفسفامید (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: پس از پیوند سیکلوفسفامید; Multiple myeloma; Haploidentical; Post-transplantation cyclophosphamide;
Keywords: پس از پیوند سیکلوفسفامید; Donor-derived malignancy; Donor cell leukemia; Post-transplantation cyclophosphamide;
Keywords: پس از پیوند سیکلوفسفامید; Allogeneic hematopoietic transplantation; Post-transplantation cyclophosphamide; Multiple myeloma;
Keywords: پس از پیوند سیکلوفسفامید; Hodgkin's disease; Non-Hodgkin lymphoma; Haploidentical stem cell transplantation; Post-transplantation cyclophosphamide; Melphalan conditioning
Keywords: پس از پیوند سیکلوفسفامید; Haploidentical; Post-transplantation cyclophosphamide; Leukemia; Peripheral blood stem cells; Pediatric
Keywords: پس از پیوند سیکلوفسفامید; Haploidentical; Post-transplantation cyclophosphamide; AML; Refractory; DLI;
Keywords: پس از پیوند سیکلوفسفامید; Haploidentical transplantation; Unrelated donor transplantation; Post-transplantation cyclophosphamide;
Keywords: پس از پیوند سیکلوفسفامید; Unrelated HCT; Graft-versus-host disease; Post-transplantation cyclophosphamide; Antithymocyte globulin;
Keywords: پس از پیوند سیکلوفسفامید; Haploidentical transplantation; Post-transplantation cyclophosphamide; Alpha-beta T cell depletion; Cellular therapy; Graft engineering
Single Antigen-Mismatched Unrelated Hematopoietic Stem Cell Transplantation Using High-Dose Post-Transplantation Cyclophosphamide Is a Suitable Alternative for Patients Lacking HLA-Matched Donors
Keywords: پس از پیوند سیکلوفسفامید; HLA-mismatched transplantation; Post-transplantation cyclophosphamide; Unrelated donor; Graft-versus-host disease;
Allogeneic: AdultCalcineurin and mTOR Inhibitor-Free Post-Transplantation Cyclophosphamide and Bortezomib Combination for Graft-versus-Host Disease Prevention after Peripheral Blood Allogeneic Hematopoietic Stem Cell Transplantation: A Phase I/II Study
Keywords: پس از پیوند سیکلوفسفامید; Allogeneic hematopoietic stem cell transplantation; Graft-versus-host disease prophylaxis; Post-transplantation cyclophosphamide; Bortezomib;
Post-Transplantation Cyclophosphamide and Ixazomib Combination Rescues Mice Subjected to Experimental Graft-versus-Host Disease and Is Superior to Either Agent Alone
Keywords: پس از پیوند سیکلوفسفامید; Post-transplantation cyclophosphamide; Proteasome inhibitors; Ixazomib; Graft-versus-host disease;
CD56-enriched donor cell infusion after post-transplantation cyclophosphamide for haploidentical transplantation of advanced myeloid malignancies is associated with prompt reconstitution of mature natural killer cells and regulatory T cells with reduced i
Keywords: پس از پیوند سیکلوفسفامید; acute myeloid leukemia; AML; donor lymphocyte infusion; DLI; haploidentical; NK cell; post-transplantation cyclophosphamide;
Comparison of Outcomes of Hematopoietic Cell Transplants from T-Replete Haploidentical Donors Using Post-Transplantation Cyclophosphamide with 10 of 10 HLA-A, -B, -C, -DRB1, and -DQB1 Allele-Matched Unrelated Donors and HLA-Identical Sibling Donors: A Mul
Keywords: پس از پیوند سیکلوفسفامید; Haploidentical; T-replete; Post-transplantation cyclophosphamide; Alternative donors
Proceedings from the Second Haploidentical Stem Cell Transplantation Symposium—Haplo2014, San Francisco, California, December 4, 2014
Keywords: پس از پیوند سیکلوفسفامید; Haploidentical transplantation; Post-transplantation cyclophosphamide; T cell depleted; Immunologic reconstitution after transplantation; Cellular therapy
Short Course of Post-Transplantation Cyclophosphamide and Bortezomib for Graft-versus-Host Disease Prevention after Allogeneic Peripheral Blood Stem Cell Transplantation Is Feasible and Yields Favorable Results: A Phase I Study
Keywords: پس از پیوند سیکلوفسفامید; Graft-versus-host disease prophylaxis; Allogeneic blood and marrow transplantation; Post-transplantation cyclophosphamide; Bortezomib;
Haploidentical Hematopoietic Stem Cell Transplantation as a Platform for Post-Transplantation Cellular Therapy
Keywords: پس از پیوند سیکلوفسفامید; Haploidentical transplantation; Post-transplantation cyclophosphamide; Alpha-beta T cell depletion; Cellular therapy; Donor lymphocyte infusion; Natural killer cells; Chimeric antigen receptor T cells
Phase II Study of Nonmyeloablative Allogeneic Bone Marrow Transplantation for B Cell Lymphoma with Post-Transplantation Rituximab and Donor Selection Based First on Non-HLA Factors
Keywords: پس از پیوند سیکلوفسفامید; Allogeneic bone marrow transplantation; Post-transplantation rituximab; Post-transplantation cyclophosphamide; Donor prioritization; Haploidentical; Fc receptor polymorphism
Post-transplantation Cyclophosphamide and Sirolimus after Haploidentical Hematopoietic Stem Cell Transplantation Using a Treosulfan-based Myeloablative Conditioning and Peripheral Blood Stem Cells
Keywords: پس از پیوند سیکلوفسفامید; Post-transplantation cyclophosphamide; Sirolimus; Peripheral blood stem cell transplantation; Allogeneic stem cell transplantation; Haploidentical transplantation;
Calcineurin Inhibitor–Free Graft-versus-Host Disease Prophylaxis with Post-Transplantation Cyclophosphamide and Brief-Course Sirolimus Following Reduced-Intensity Peripheral Blood Stem Cell Transplantation
Keywords: پس از پیوند سیکلوفسفامید; Post-transplantation cyclophosphamide; Sirolimus; Peripheral blood stem cell transplantation; Graft-versus-host disease; Allogeneic; Reduced-intensity conditioning
Absence of Post-Transplantation Lymphoproliferative Disorder after Allogeneic Blood or Marrow Transplantation Using Post-Transplantation Cyclophosphamide as Graft-versus-Host Disease Prophylaxis
Keywords: پس از پیوند سیکلوفسفامید; Post-transplantation lymphoproliferative disorder; Allogeneic blood or marrow transplantation; Post-transplantation cyclophosphamide; Graft-versus-host disease prophylaxis
Antigen and Lymphopenia-Driven Donor T Cells Are Differentially Diminished by Post-Transplantation Administration of Cyclophosphamide after Hematopoietic Cell Transplantation
Keywords: پس از پیوند سیکلوفسفامید; Allogeneic-hematopoietic stem cell transplantation (HSCT); Graft-versus-host disease (GVHD); Lymphopenia-induced proliferation; Alkylating agent; Post-transplantation cyclophosphamide; Myeloablative conditioning